Hills Bank & Trust’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $407K | Hold |
5,086
| – | – | 0.02% | 227 |
|
|
2025
Q4 | $434K | Hold |
5,086
| – | – | 0.03% | 214 |
|
|
2025
Q3 | $396K | Hold |
5,086
| – | – | 0.02% | 212 |
|
|
2025
Q2 | $398K | Buy |
5,086
+240
| +5% | +$17.9K | 0.03% | 209 |
|
|
2025
Q1 | $351K | Hold |
4,846
| – | – | 0.02% | 209 |
|
|
2024
Q4 | $359K | Hold |
4,846
| – | – | 0.03% | 209 |
|
|
2024
Q3 | $320K | Hold |
4,846
| – | – | 0.02% | 218 |
|
|
2024
Q2 | $448K | Hold |
4,846
| – | – | 0.04% | 182 |
|
|
2024
Q1 | $463K | Hold |
4,846
| – | – | 0.04% | 179 |
|
|
2023
Q4 | $370K | Hold |
4,846
| – | – | 0.04% | 183 |
|
|
2023
Q3 | $336K | Hold |
4,846
| – | – | 0.04% | 174 |
|
|
2023
Q2 | $457K | Hold |
4,846
| – | – | 0.06% | 149 |
|
|
2023
Q1 | $401K | Hold |
4,846
| – | – | 0.06% | 154 |
|
|
2022
Q4 | $362K | Hold |
4,846
| – | – | 0.05% | 152 |
|
|
2022
Q3 | $400K | Hold |
4,846
| – | – | 0.06% | 149 |
|
|
2022
Q2 | $461K | Hold |
4,846
| – | – | 0.07% | 137 |
|
|
2022
Q1 | $570K | Sell |
4,846
-54
| -1% | -$6.06K | 0.08% | 132 |
|
|
2021
Q4 | $635K | Hold |
4,900
| – | – | 0.09% | 131 |
|
|
2021
Q3 | $555K | Buy |
+4,900
| New | +$559K | 0.08% | 132 |
|
|
2021
Q1 | – | Sell |
-4,975
| Closed | -$454K | – | 257 |
|
|
2020
Q4 | $454K | Hold |
4,975
| – | – | 0.08% | 136 |
|
|
2020
Q3 | $397K | Sell |
4,975
-1,025
| -17% | -$80K | 0.08% | 134 |
|
|
2020
Q2 | $415K | Hold |
6,000
| – | – | 0.09% | 129 |
|
|
2020
Q1 | $377K | Hold |
6,000
| – | – | 0.11% | 103 |
|
|
2019
Q4 | $467K | Hold |
6,000
| – | – | 0.11% | 108 |
|
|
2019
Q3 | $440K | Hold |
6,000
| – | – | 0.11% | 108 |
|
|
2019
Q2 | $369K | Hold |
6,000
| – | – | 0.1% | 118 |
|
|
2019
Q1 | $383K | Sell |
6,000
-405
| -6% | -$23.1K | 0.1% | 116 |
|
|
2018
Q4 | $327K | Hold |
6,405
| – | – | 0.1% | 114 |
|
|
2018
Q3 | $372K | Hold |
6,405
| – | – | 0.1% | 113 |
|
|
2018
Q2 | $311K | Hold |
6,405
| – | – | 0.09% | 113 |
|
|
2018
Q1 | $298K | Sell |
6,405
-1,125
| -15% | -$48.9K | 0.09% | 111 |
|
|
2017
Q4 | $283K | Hold |
7,530
| – | – | 0.08% | 114 |
|
|
2017
Q3 | $274K | Sell |
7,530
-1,350
| -15% | -$51.5K | 0.09% | 113 |
|
|
2017
Q2 | $350K | Hold |
8,880
| – | – | 0.11% | 105 |
|
|
2017
Q1 | $278K | Hold |
8,880
| – | – | 0.09% | 110 |
|
|
2016
Q4 | $277K | Hold |
8,880
| – | – | 0.1% | 112 |
|
|
2016
Q3 | $357K | Hold |
8,880
| – | – | 0.13% | 103 |
|
|
2016
Q2 | $295K | Sell |
8,880
-600
| -6% | -$20.5K | 0.11% | 107 |
|
|
2016
Q1 | $279K | Buy |
9,480
+600
| +7% | +$16.6K | 0.1% | 106 |
|
|
2015
Q4 | $234K | Hold |
8,880
| – | – | 0.09% | 102 |
|
|
2015
Q3 | $210K | Hold |
8,880
| – | – | 0.08% | 90 |
|
|
2015
Q2 | $211K | Hold |
8,880
| – | – | 0.08% | 82 |
|
|
2015
Q1 | $211K | Buy |
+8,880
| New | +$199K | 0.08% | 84 |
|
Other funds holding EW
VCM
VPM
Hills Bank & Trust's EW Position: Q1 2026 in Review
Hills Bank & Trust held its Edwards Lifesciences (EW) position steady in Q1 2026 at 5,086 shares worth $407K. The position accounts for 0.02% of the portfolio, ranked #227.
Hills Bank & Trust first reported a position in EW in Q1 2015 and has held it in 43 quarters since. The position peaked at $635K in Q4 2021. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Hills Bank & Trust held 5,086 shares of Edwards Lifesciences worth $407K as of Q1 2026.
- Hills Bank & Trust left its Edwards Lifesciences share count unchanged in Q1 2026.
- Edwards Lifesciences made up 0.02% of Hills Bank & Trust's portfolio in Q1 2026, its #227 holding.
- Hills Bank & Trust first reported a position in Edwards Lifesciences in Q1 2015 and has held it in 43 quarters since.
- Hills Bank & Trust's Edwards Lifesciences position peaked at $635K in Q4 2021.
- 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Hills Bank & Trust's 13F filing for Q1 2026, filed 1 May 2026.